SA
Log In
CME
OverviewIntelligenceChart

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
18 analysts·Moderate coverage
50%
Rating Distribution
Strong Buy
00%
Buy
950%
Hold
528%
Sell
422%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 10% higher.

Bear Case
$300.00
+4%
Consensus
$317.20
+10%
Bull Case
$362.00
+26%
Price Range18 analysts
Low
Consensus
High
$300.00
$362.00
Current Target
Current Price
$287.65
Upside to Target
$29.55

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+4.31%
EPS+4.87%
FY2028
Rev+6.96%
EPS+6.94%
FY2029
Rev+5.80%
EPS+7.64%

Earnings Surprises

Recent Analyst Actions

Apr 10, 2026Morgan Stanley
CME Group price target raised to $362 from $340 at Morgan Stanley
Target:$362.00
+22.8%from $294.81
Feb 6, 2026UBS
CME Group price target raised to $310 from $280 at UBS
Target:$310.00
+4.2%from $297.38
Feb 5, 2026RBC Capital
CME Group price target raised to $302 from $295 at RBC Capital
Target:$302.00
+0.5%from $300.42
Feb 5, 2026Morgan Stanley
CME Group price target raised to $340 from $319 at Morgan Stanley
Target:$340.00
+15.4%from $294.62
Feb 5, 2026Barclays
CME Group price target raised to $312 from $304 at Barclays
Target:$312.00
+5.9%from $294.62
Jan 15, 2026Morgan Stanley
CME Group price target lowered to $319 from $320 at Morgan Stanley
Target:$319.00
+16.7%from $273.41
Dec 22, 2025Morgan Stanley
CME Group price target raised to $320 from $314 at Morgan Stanley
Target:$320.00
+18.9%from $269.09
Dec 12, 2025Barclays
CME Group price target raised to $304 from $280 at Barclays
Target:$304.00
+11.6%from $272.42
Oct 23, 2025Morgan Stanley
CME Group price target raised to $314 from $312 at Morgan Stanley
Target:$314.00
+16.5%from $269.50
Oct 23, 2025UBS
CME Group price target lowered to $280 from $285 at UBS
Target:$280.00
+4.6%from $267.81
Oct 23, 2025Deutsche Bank
CME Group upgraded to Buy from Hold at Deutsche Bank
Target:$300.00
+11.3%from $269.59
Oct 13, 2025Raymond James
CME Group price target lowered to $307 from $309 at Raymond James
Target:$307.00
+13.1%from $271.45
Oct 8, 2025Barclays
CME Group price target lowered to $280 from $298 at Barclays
Target:$280.00
+6.2%from $263.60
Oct 1, 2025Morgan Stanley
CME Group price target raised to $312 from $303 at Morgan Stanley
Target:$312.00
+18.0%from $264.46
Sep 8, 2025UBS
CME Group price target lowered to $285 from $305 at UBS
Target:$285.00
+8.9%from $261.78
Jul 24, 2025Barclays
CME Group price target lowered to $298 from $299 at Barclays
Target:$298.00
+7.5%from $277.18
Mar 10, 2025Raymond James
CME Group upgraded to Outperform from Market Perform at Raymond James
Target:$287.00
+12.7%from $254.57
Oct 24, 2024Oppenheimer
CME Group (CME) PT Raised to $258 at Oppenheimer
Target:$258.00
+13.4%from $227.43
Oct 24, 2024Barclays
CME Group price target raised to $231 from $219 at Barclays
Target:$231.00
+1.7%from $227.14
Oct 3, 2024Citigroup
CME Group price target raised to $250 from $240 at Citi
Target:$250.00
+11.8%from $223.57
Sep 26, 2024RBC Capital
CME Group initiated with a Sector Perform at RBC Capital
Target:$235.00
+7.6%from $218.47
Sep 3, 2024Bank of America Securities
CME Group downgraded to Underperform from Neutral at BofA
Target:$177.00
-18.0%from $215.74
Jul 25, 2024Deutsche Bank
CME Group price target lowered to $193 from $195 at Deutsche Bank
Target:$193.00
-3.0%from $198.92
Jul 25, 2024Piper Sandler
CME Group (CME) PT Lowered to $225 at Piper Sandler
Target:$225.00
+12.8%from $199.38
Jul 25, 2024Barclays
CME Group price target raised to $209 from $208 at Barclays
Target:$209.00
+6.0%from $197.25

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance